Safety and Pharmacokinetics of ONC201 (dordaviprone) Administered Two Consecutive Days Per Week in Pediatric Patients with H3 K27M-mutant Glioma.
Yazmin Odia,Carl Koschmann,Nicholas A Vitanza,Peter de Blank,Dolly Aguilera,Jeffrey Allen,Doured Daghistani,Matthew Hall,Ziad Khatib,Cassie Kline,Tobey MacDonald,Sabine Mueller, Shamia L Faison,Joshua E Allen,Odin J Naderer,Samuel C Ramage,Rohinton S Tarapore,Susan Lynne McGovern,Soumen Khatua,Wafik Zaky,Sharon L Gardner Neuro-oncology（2024）
AI 理解论文
溯源树
样例
